[{"Assets_0_Q3_USD":435047000.0,"CommonStockSharesOutstanding_0_Q3_shares":42488312.0,"NetIncomeLoss_1_Q3_USD":-79227000.0,"NetIncomeLoss_3_Q3_USD":-220408000.0,"StockholdersEquity_0_Q3_USD":365558000.0,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171103"}]